FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent for preventing heart rhythm disorders caused by metabolic disturbance. The agent for preventing heart rhythm disorders caused by metabolic disturbance, divided in two solid preparative forms; the first solid preparative form comprises taurine, potassium citrate and additive agents, whereas the second preparative form contains L-arginine, magnesium dicitrate and additive agents in certain proportions.
EFFECT: agent is effective for preventing heart rhythm disorders caused by metabolic disturbance.
3 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| INFUSION SOLUTION TO TREAT CARDIOVASCULAR SYSTEM DISEASES | 2000 |
|
RU2178296C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | 1999 |
|
RU2168989C1 |
| COMPOSITION CONTAINING MONEYWORT EXTRACT FOR PREVENTING AND TREATING METABOLIC DISORDERS | 2008 |
|
RU2481851C2 |
| BIOLOGICALLY ACTIVE ADDITIVE FOR INCREASING GENERAL WORKING ABILITY | 2016 |
|
RU2635373C1 |
| BIOLOGICALLY ACTIVE SUPPLEMENT "VITABS KARDIO" FOR PROPHYLAXIS OF CARDIOVASCULAR DISEASE | 2005 |
|
RU2312674C2 |
| METHOD OF TREATING LIPIDOSIS AND BODY-WEIGHT REDUCTION IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2008 |
|
RU2384340C2 |
| FUKOLAMINE PREPARATION FOR PREVENTING AND TREATING GASTROENTERIC AND ENDOCRINE SYSTEM DISEASES | 2005 |
|
RU2297234C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CARDIOVASCULAR DISEASES | 2019 |
|
RU2723484C1 |
| ANTI-ISCHEMIC REMEDY POSSESSING ANTI-ARRHYTHMIC AND ANTI-ATHEROGENIC ACTIVITY AND METHOD FOR APPLYING THE MEANS | 2004 |
|
RU2259822C1 |
